189 related articles for article (PubMed ID: 28806730)
1. A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
Aurich MK; Fleming RMT; Thiele I
PLoS Comput Biol; 2017 Aug; 13(8):e1005698. PubMed ID: 28806730
[TBL] [Abstract][Full Text] [Related]
2. Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells.
Filipp FV; Scott DA; Ronai ZA; Osterman AL; Smith JW
Pigment Cell Melanoma Res; 2012 May; 25(3):375-83. PubMed ID: 22360810
[TBL] [Abstract][Full Text] [Related]
3. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells.
Smolková K; Dvořák A; Zelenka J; Vítek L; Ježek P
Int J Biochem Cell Biol; 2015 Aug; 65():125-33. PubMed ID: 26007236
[TBL] [Abstract][Full Text] [Related]
4. (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
Cuperlovic-Culf M; Cormier K; Touaibia M; Reyjal J; Robichaud S; Belbraouet M; Turcotte S
Int J Cancer; 2016 May; 138(10):2439-49. PubMed ID: 26620126
[TBL] [Abstract][Full Text] [Related]
5. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
[TBL] [Abstract][Full Text] [Related]
6. Functional modules, structural topology, and optimal activity in metabolic networks.
Resendis-Antonio O; Hernández M; Mora Y; Encarnación S
PLoS Comput Biol; 2012; 8(10):e1002720. PubMed ID: 23071431
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of metabolomics in oncology: a review.
Spratlin JL; Serkova NJ; Eckhardt SG
Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
[TBL] [Abstract][Full Text] [Related]
8. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.
Wen H; Cho HR; Yun T; Kim H; Park CK; Lee SH; Choi SH; Park S
J Neurochem; 2015 Jan; 132(2):183-93. PubMed ID: 25251602
[TBL] [Abstract][Full Text] [Related]
10. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.
Metallo CM; Gameiro PA; Bell EL; Mattaini KR; Yang J; Hiller K; Jewell CM; Johnson ZR; Irvine DJ; Guarente L; Kelleher JK; Vander Heiden MG; Iliopoulos O; Stephanopoulos G
Nature; 2011 Nov; 481(7381):380-4. PubMed ID: 22101433
[TBL] [Abstract][Full Text] [Related]
11. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
12. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
13. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling.
Kim HY; Lee H; Kim SH; Jin H; Bae J; Choi HK
Sci Rep; 2017 Aug; 7(1):8864. PubMed ID: 28821754
[TBL] [Abstract][Full Text] [Related]
15. Connecting extracellular metabolomic measurements to intracellular flux states in yeast.
Mo ML; Palsson BO; Herrgård MJ
BMC Syst Biol; 2009 Mar; 3():37. PubMed ID: 19321003
[TBL] [Abstract][Full Text] [Related]
16. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.
Nájera L; Alonso-Juarranz M; Garrido M; Ballestín C; Moya L; Martínez-Díaz M; Carrillo R; Juarranz A; Rojo F; Cuezva JM; Rodríguez-Peralto JL
Br J Dermatol; 2019 Jul; 181(1):114-127. PubMed ID: 30537064
[TBL] [Abstract][Full Text] [Related]
18. Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
Abaffy T; Duncan R; Riemer DD; Tietje O; Elgart G; Milikowski C; DeFazio RA
PLoS One; 2010 Nov; 5(11):e13813. PubMed ID: 21079799
[TBL] [Abstract][Full Text] [Related]
19. In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation.
Gameiro PA; Yang J; Metelo AM; Pérez-Carro R; Baker R; Wang Z; Arreola A; Rathmell WK; Olumi A; López-Larrubia P; Stephanopoulos G; Iliopoulos O
Cell Metab; 2013 Mar; 17(3):372-85. PubMed ID: 23473032
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
